Insulin Degludec / Liraglutide (Addendum to Commission A15-15) [Internet].

Background On 8 September 2015, the Federal Joint Committee (G-BA) commissioned the Institute for Quality and Efficiency in Health Care (IQWiG) to conduct a supplementary assessment for Commission A15-15 (Insulin degludec/liraglutide – Benefit assessment according to §35a SGB V).

http://ift.tt/2mAwSUJ